Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR

被引:39
作者
Wilke, M [1 ]
Pool, J [1 ]
den Haan, JMM [1 ]
Goulmy, E [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Bloodbank, NL-2333 ZA Leiden, Netherlands
来源
TISSUE ANTIGENS | 1998年 / 52卷 / 04期
关键词
bone marrow transplantation; genomic typing; graft-versus-host disease; HA-1; minor histocompatibility antigen;
D O I
10.1111/j.1399-0039.1998.tb03053.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Graft-versus-host disease (GvHD) can be a major complication of allogeneic bone marrow transplantation even in recipients of HLA genotype-identical transplants. Disparities in minor histocompatibility antigens (mHags) between donor and recipient are a potential risk for the development of GVHD. A mismatch for the mHag HA-1 can cause GVHD in adult recipients of allogeneic bone marrow from HLA-identical donors. The mHag HAi, 1, first identified by HLA-A*0201-restricted cytotoxic T cells (CTLs), was recently chemically characterized as a nonapeptide. On the cDNA level, the HA-1 locus has two alleles, HA-1(H) and HA-1(R), which differ in two nucleotides, resulting in a single amino acid substitution. Here we report on the genomic structure of the HA-1 locus. Isolation and sequencing of cosmid DNA encoding the HA-1 peptide sequence revealed that the HA-I alleles are encoded by two exons. Two different primer sets were designed each consisting of allele-specific primers and a common primer, and both sets containing intronic sequences. We performed genomic DNA typing of three families consisting of 24 HLA-A*0201-positive individuals. The predicted allele-specific products correlated in all cases with the mHag classification by CTLs and by RT-PCR. We demonstrate for the first time the genomic identification of the mHag HA-1 locus. Prospective genomic typing for the HA-1 alleles will improve donor selection and identify HLA-A*0201-positive recipients with a high risk for HA-1-induced GvHD.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 22 条
[1]  
Behar E, 1996, NEW ENGL J MED, V334, P286, DOI 10.1056/NEJM199602013340502
[2]  
BHYAN PK, 1997, J IMMUNOL, V158, P3753
[3]  
DaCosta L, 1997, BLOOD, V90, P1332
[4]   The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism [J].
den Haan, JMM ;
Meadows, LM ;
Wang, W ;
Pool, J ;
Blokland, E ;
Bishop, TL ;
Reinhardus, C ;
Shabanowitz, J ;
Offringa, R ;
Hunt, DF ;
Engelhard, VH ;
Goulmy, E .
SCIENCE, 1998, 279 (5353) :1054-1057
[5]   IDENTIFICATION OF A GRAFT-VERSUS-HOST DISEASE-ASSOCIATED HUMAN MINOR HISTOCOMPATIBILITY ANTIGEN [J].
DENHAAN, JMM ;
SHERMAN, NE ;
BLOKLAND, E ;
HUCZKO, E ;
KONING, F ;
DRIJFHOUT, JW ;
SKIPPER, J ;
SHABANOWITZ, J ;
HUNT, DF ;
ENGELHARD, VH ;
GOULMY, E .
SCIENCE, 1995, 268 (5216) :1476-1480
[6]  
Fischer Lindahl K., 1995, Biochemical Society Transactions, V23, P669
[7]   Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation [J].
Goulmy, E ;
Schipper, R ;
Pool, J ;
Blokland, E ;
Falkenburg, JHF ;
Vossen, J ;
Gratwohl, A ;
Vogelsang, GB ;
vanHouwelingen, HC ;
vanRood, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :281-285
[8]   A MINOR TRANSPLANTATION ANTIGEN DETECTED BY MHC-RESTRICTED CYTO-TOXIC LYMPHOCYTES-T DURING GRAFT-VERSUS-HOST DISEASE [J].
GOULMY, E ;
GRATAMA, JW ;
BLOKLAND, E ;
ZWAAN, FE ;
VANROOD, JJ .
NATURE, 1983, 302 (5904) :159-161
[9]   Human minor histocompatibility antigens [J].
Goulmy, E .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (01) :75-81
[10]   Human minor histocompatibility antigens: New concepts for marrow transplantation and adoptive immunotherapy [J].
Goulmy, E .
IMMUNOLOGICAL REVIEWS, 1997, 157 :125-140